Binding Site News Today

Operator: Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 First Quarter Conference Call. My name is Angela, and Ill be coordinating your call today.

TMO earnings call for the period ending March 31, 2024.

Transforming monoclonal gammopathy management to address an unmet clinical need through an innovative MS solution

Transforming monoclonal gammopathy management to address an unmet clinical need through an innovative MS solution

Small Molecule Innovator CDMO MarketThe Small Molecule Innovator CDMO Market is expected to be worth US$ 48.09 billion in 2023, rising to US$ 89.43 billion by 2033. During the forecast period, sales of small molecule innovator CDMO are expected to grow at a significant CAGR of 6.4%.The small molecule innovator contr...

Thermo Fisher Scientific Inc. (NYSE:TMO) Q3 2023 Earnings Call Transcript October 25, 2023 Operator: Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2023 Third Quarter Conference Call. My name is Ellen and I’ll be the operator for today’s call. During the presentation, all lines will be on mute. However, there will […]

TMO earnings call for the period ending September 30, 2023.

BANGKOK, Thailand, Oct. 21, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) announced that it will be holding its first-ever Asian Myeloma Network (AMN) awards ceremony this year, during the 7th

Hematologists are heralding a new era in multiple myeloma. Experts discuss how times have changed.

Thermo Fisher Scientific the world leader in serving science today announced the commercial launch of the EXENT Solution after receiving IVDR certification.